Rhythm Pharmaceuticals, Inc.
News
Investors Purchase Large Volume of Rhythm Pharmaceuticals Call Options (NASDAQ:RYTM)
Ticker Report Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) saw unusually large options trading on Wednesday. Investors acquired 3,047 call options on the stock. This is an increase of 988% compared...\n more…
Biotech Stock Near Buy Point Amid Impressive Sales Track Record
Investor's Business Daily Rhythm Pharmaceuticals is near a buy point after strong sales in the second quarter.\nThe post Biotech Stock Near Buy Point Amid Impressive Sales Track Record appeared first on Investor's Business...\n more…
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of "Moderate Buy" from Brokerages
Ticker Report Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six analysts that are currently covering the stock, MarketBeat...\n more…
National Bank of Canada FI Boosts Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Ticker Report National Bank of Canada FI increased its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 10.0% during the second quarter, according to its most recent Form 13F...\n more…
Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 3,200 Shares of Stock
Ticker Report Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) insider Pamela J. Cramer sold 3,200 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price...\n more…
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Director Lynn A. Tetrault Sells 4,300 Shares
Ticker Report Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) Director Lynn A. Tetrault sold 4,300 shares of the company's stock in a transaction dated Monday, August 26th. The stock was sold at an...\n more…